[Federal Register Volume 87, Number 16 (Tuesday, January 25, 2022)]
[Notices]
[Page 3828]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-01367]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Heart, Lung, and Blood Institute; Notice of Closed 
Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Heart, Lung, and Blood Institute 
Special Emphasis Panel; Cardiovascular Disease Risk and Diet Induced 
Circadian Dysfunction.
    Date: March 3, 2022.
    Time: 9:00 a.m. to 12:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6705 Rockledge Drive, 
Bethesda, MD 20817 (Virtual Meeting).
    Contact Person: Shelley S. Sehnert, Ph.D., Scientific Review 
Officer, Office of Scientific Review/DERA, National Heart, Lung, and 
Blood Institute, National Institutes of Health, 6705 Rockledge 
Drive, Room 208-T, Bethesda, MD 20892-7924, (301) 827-7984, 
<a href="/cdn-cgi/l/email-protection#0e7d7d6b66606b7c7a4e6066626c672060676620696178"><span class="__cf_email__" data-cfemail="ee9d9d8b86808b9c9aae8086828c87c0808786c0898198">[email protected]</span></a>.

    Name of Committee: National Heart, Lung, and Blood Institute 
Special Emphasis Panel; Career Development Program to Promote 
Diversity in Health Research.
    Date: March 4, 2022.
    Time: 10:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6705 Rockledge Drive, 
Bethesda, MD 20817 (Virtual Meeting).
    Contact Person: Sun Saret, Ph.D., Scientific Review Officer, 
Office of Scientific Review/DERA, National Heart, Lung, and Blood 
Institute, National Institutes of Health, 6705 Rockledge Drive, Room 
208-S, Bethesda, MD 20892, (301) 435-0270, <a href="/cdn-cgi/l/email-protection#1e6d6b70306d7f6c7b6a5e70777630797168"><span class="__cf_email__" data-cfemail="e596908bcb9684978091a58b8c8dcb828a93">[email protected]</span></a>.

    Name of Committee: National Heart, Lung, and Blood Institute 
Special Emphasis Panel; Early Phase Clinical Trials (R61, R33).
    Date: March 7, 2022.
    Time: 10:00 a.m. to 4:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6705 Rockledge Drive, 
Bethesda, MD 20817 (Virtual Meeting).
    Contact Person: Manoj Kumar Valiyaveettil, Ph.D., Scientific 
Review Officer, Office of Scientific Review/DERA, National Heart, 
Lung, and Blood Institute, National Institutes of Health, 6705 
Rockledge Drive, Room 208-R, Bethesda, MD 20817, (301) 402-1616, 
<a href="/cdn-cgi/l/email-protection#4d202c232227633b2c2124342c3b2828393924210d232425632a223b"><span class="__cf_email__" data-cfemail="85e8e4ebeaefabf3e4e9ecfce4f3e0e0f1f1ece9c5ebecedabe2eaf3">[email protected]</span></a>.

    Name of Committee: National Heart, Lung, and Blood Institute 
Special Emphasis Panel; Hemophilia A Analytical Cohort Research 
Program (UG3/UH3).
    Date: March 22, 2022.
    Time: 11:00 a.m. to 2:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6705 Rockledge Drive, 
Bethesda, MD 20817, (Virtual Meeting).
    Contact Person: Manoj Kumar Valiyaveettil, Ph.D., Scientific 
Review Officer, Office of Scientific Review/DERA, National Heart, 
Lung, and Blood Institute, National Institutes of Health, 6705 
Rockledge Drive, Room 208-R, Bethesda, MD 20817, (301) 402-1616, 
<a href="/cdn-cgi/l/email-protection#f598949b9a9fdb8394999c8c9483909081819c99b59b9c9ddb929a83"><span class="__cf_email__" data-cfemail="c6aba7a8a9ace8b0a7aaafbfa7b0a3a3b2b2afaa86a8afaee8a1a9b0">[email protected]</span></a>.

    Name of Committee: National Heart, Lung, and Blood Institute 
Special Emphasis Panel; Limited Competition: Small Grant Program for 
NHLBI K01/K08/K23 Recipients (R03--Clinical Trial Optional).
    Date: March 23, 2022.
    Time: 10:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6705 Rockledge Drive, 
Bethesda, MD 20817 (Virtual Meeting).
    Contact Person: Kazuyo Kegan, AB, Ph.D., Scientific Review 
Officer, Office of Scientific Review/DERA, National Heart, Lung and 
Blood Institute, National Institutes of Health, 6705 Rockledge 
Drive, Room 208-S, Bethesda, MD 20817, (301) 435-0270, 
<a href="/cdn-cgi/l/email-protection#c1aaa0bbb4b8aeefaaa4a6a0af81afa8a9efa6aeb7"><span class="__cf_email__" data-cfemail="e2898398979b8dcc898785838ca28c8b8acc858d94">[email protected]</span></a>.

(Catalogue of Federal Domestic Assistance Program Nos. 93.233, 
National Center for Sleep Disorders Research; 93.837, Heart and 
Vascular Diseases Research; 93.838, Lung Diseases Research; 93.839, 
Blood Diseases and Resources Research, National Institutes of 
Health, HHS)

    Dated: January 19, 2022.
David W Freeman,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2022-01367 Filed 1-24-22; 8:45 am]
BILLING CODE 4140-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>